Spots Global Cancer Trial Database for atypical ductal breast hyperplasia
Every month we try and update this database with for atypical ductal breast hyperplasia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer | NCT01874184 | Atypical Ductal... Atypical Lobula... BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... | counseling inte... behavioral diet... exercise interv... questionnaire a... laboratory biom... | 35 Years - 65 Years | University of Washington | |
| Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia | NCT00627276 | Breast Cancer Precancerous Co... | omega-3 fatty a... placebo | 21 Years - 120 Years | OHSU Knight Cancer Institute | |
| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer | NCT01905046 | Atypical Ductal... BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... | metformin hydro... placebo | 25 Years - 55 Years | Alliance for Clinical Trials in Oncology | |
| A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer | NCT00637481 | Atypical Ductal... Breast Cancer Ductal Breast C... Lobular Breast ... | atorvastatin ca... laboratory biom... | 18 Years - 72 Years | National Cancer Institute (NCI) | |
| A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer | NCT00637481 | Atypical Ductal... Breast Cancer Ductal Breast C... Lobular Breast ... | atorvastatin ca... laboratory biom... | 18 Years - 72 Years | National Cancer Institute (NCI) | |
| Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer | NCT00794989 | Breast Cancer Precancerous Co... | Ground Flaxseed No Intervention | 21 Years - 50 Years | Roswell Park Cancer Institute | |
| Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer | NCT00794989 | Breast Cancer Precancerous Co... | Ground Flaxseed No Intervention | 21 Years - 50 Years | Roswell Park Cancer Institute | |
| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer | NCT01905046 | Atypical Ductal... BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... | metformin hydro... placebo | 25 Years - 55 Years | Alliance for Clinical Trials in Oncology | |
| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer | NCT01905046 | Atypical Ductal... BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... | metformin hydro... placebo | 25 Years - 55 Years | Alliance for Clinical Trials in Oncology | |
| Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer | NCT00666731 | Breast Cancer Precancerous Co... | medical chart r... questionnaire a... study of socioe... Excess human bi... quality-of-life... | 19 Years - 120 Years | University of Nebraska | |
| A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer | NCT00637481 | Atypical Ductal... Breast Cancer Ductal Breast C... Lobular Breast ... | atorvastatin ca... laboratory biom... | 18 Years - 72 Years | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
